An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (126)
  • Training (0)
  • User case (2)
  • User meeting (1)
  • Webinar (6)
  • White paper (1)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • (-) Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • (-) Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)
  • Reset filters
  • (-) Gastro-intestinal
  • (-) Ocular

Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.

11/12/2019
/ Publications
/
Hypofractionation
Survival

This study by MGH retrospectively analyzed 66 patients with unresectable intrahepatic cholangiocarcinoma (ICC) who were treated with hypofractionated proton (32...

Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System.

01/02/2020
/ Publications
/
FLASH Therapy

Published in the Red Journal by the UPenn group, this paper reported the effect of FLASH proton versus standard dose rate PRT on tumors and normal tissues in...

Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer.

01/01/2020
/ Publications
/
Survival

This paper reviews the current status of photon and particle radiation therapy for pancreatic cancer in combination with systemic therapies and hypoxia...

Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence.

01/01/2020
/ Publications
/
Chemotherapy
Survival

This study from Japan reported the efficacy of 44 clinical T1 esophageal cancer patients treated with concurrent chemo-proton therapy (CCPT). 43 patients (98%)...

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.

03/03/2020
/ Publications
/
IMRT
IMPT

Published in JCO (Journal of Clinical Oncology), this randomized trial compared total toxicity burden (TTB) and progression-free survival (PFS) between PBT and...

The emerging role of proton therapy for esophagus cancer.

03/02/2020
/ Publications
/
Survival

This review article discussed the emerging role of PBT for esophageal cancer, including rationale, treatment planning, early dosimetric and clinical comparisons...

Proton beam therapy for liver cancers.

03/02/2020
/ Publications
/
Dosimetry
Toxicity

A review article examined the latest utilization of PBT for hepatocellular carcinoma and cholangiocarcinoma, as well as liver metastasis. The dosimetric...

Proton beam radiotherapy for pancreas cancer.

03/02/2020
/ Publications
/
Hypofractionation
Chemotherapy

A review article examined up to date data of PBT for pancreatic cancer. For both resectable and unresectable pancreatic cancer, the clinical outcome data is...

Proton beam radiotherapy for anal and rectal cancers.

03/02/2020
/ Publications
/
Hypofractionation

A review article looked at the current status of PBT for anal and rectal cancers. PBT offers appealing potential to reduce toxicity, increase patient compliance...

Proton beam re-irradiation for gastrointestinal malignancies: a systematic review.

03/02/2020
/ Publications
/
Reirradiation

A systematic review assessing for reports of proton-beam reirradiation for recurrent or second primary GI cancers. 7 included studies reported on proton-beam re...

Pagination

  • Previous page ‹
    • Page 3
    • Current page 4
    • Page 5
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies